T. Araida et al., THERAPEUTIC REGIMENS IN ACUTE EXPERIMENTAL PANCREATITIS IN RATS - EFFECTS OF A PROTEASE INHIBITOR, A BETA-AGONIST, AND ANTIBIOTICS, Pancreas, 11(2), 1995, pp. 132-140
The osmolality of contrast injected retrograde into the rat pancreatic
duct did not affect the severity of the pancreatitis (Urografin, 1,30
0 mOsm/kg, and Hexabrix, 580 mOsm/kg). The severity of the pancreatiti
s induced in rats was assessed by survival rate, histologic grading, w
et lung ratio, and serum levels of amylase, lipase, and trypsin-like a
ctivity. Rats with pancreatitis induced by retrograde injected Urograf
in, lipopolysaccharide, taurocholic acid plus enterokinase were treate
d with either intravenous (i.v.) FUT-175 (Nafamstat Mesilate), FUT-175
administered by retrograde pancreatic injection, i.v. terbutaline, i.
v. piperacillin sodium, piperacillin sodium by retrograde pancreatic d
uct injection, or a combination of FUT-175 plus terbutaline and pipera
cillin. Survival among the rats was increased and the incidence of pan
creatic infection reduced in rats treated with i.v. piperacillin or wi
th a combination of FUT-175 plus i.v. terbutaline, plus i.v. piperacil
lin compared to controls.